Akamai estimates about US$5.5B in capex tied to its US$11.6B Anthropic deal; first services are planned for late second ...

FDA approval covers FOP patients 12 and older after a 63-patient trial; Mirum expects Atebrioz to become available in the U.S ...

The FDA expanded Olumiant to severe alopecia areata patients 12 and older after a trial showed 42 per cent response on 4 mg.

WISeKey expects its merger into WISeQey on Oct. 2, with ordinary shares due to start Nasdaq and SIX trading on Oct. 5.

Rexel plans about €800M in cash and debt and a possible €500M equity sale to fund its GCG acquisition, targeted to close by ...

Nanexa closed Sept. 25 at SEK 12.16 after a Novo Nordisk licence worth up to €1.165B in upfront and conditional payments.

Merck and Daiichi Sankyo withdrew the ifinatamab BLA on Sept. 25 after FDA discussions; the Oct. 10 action date had been set.

Bonza Sur hole BLP-2026-553 cut 3.05 metres at 204.26 grams per tonne gold, while Quebrada Dorada extended the trend beyond ...

NRC staff found PG&E's Diablo Canyon Unit 1 capsule report met federal rules on Sept. 24; the plant's licences were renewed ...

Cresco Labs is asking holders to approve three changes on Oct. 30, including a share exchange and a possible move to Delaware ...

Six of 10 higher-dose ALTITUDE participants improved by more than two DRSS steps at three years; NAAVIGATE is testing the ...

FERC's Sept. 24 notice sets an Oct. 13 intervention deadline for Transco's US$54.7M Pennsylvania loop, with late 2027 service ...